To confirm that RANKL/RANK signaling recruits Tregs via the CCL20–CCR6 pathway, we discovered that CCR6 and FOXP3 were colocalized in the blood (Fig. 5c) and tumor tissue (Fig. 5d) of CRC. This evidence concerns the gene CCL20 and colorectal carcinoma.